Peptide-drug conjugates
MA40030AUndetermined Publication Date: 2015-12-10JIARUI BIOPHARMACEUTICALS LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA40030
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-06-03
- Filing Date
- 2015-06-01
- Publication Date
- 2015-12-10
Abstract
Peptide-drug conjugates comprising p-aminobenzyl carbamoyl or p-aminobenzolyl carbonate self-immolating linkers are disclosed. The peptide-drug conjugates comprise a peptide moiety that can be cleaved by cellular proteases, bound to the self-immolating linker, which linker is bound to a cytotoxic drug moiety. Upon cleavage of the peptide moiety, the linker self- immolates, releasing the cytotoxic drug in active form. Dimeric structures of the peptide drug conjugates comprising two molecules of cytotoxic drug per conjugate are also disclosed.
Need to check novelty before this filing date? Find Prior Art